FDA Approves Rezdiffra, First Treatment for Fatty Liver (Actually NASH): Everything You Need to Know
The U.S. Food and Drug Administration has approved, for the first time ever, a drug that can be used by those suffering from fatty liver disease. The drug, called Rezdiffra (active ingredient: resmetirom), will be used for the treatment of adults with non-alcoholic steatohepatitis (NASH), now called MASH (metabolic dysfunction-associated steatohepatitis), with moderate to advanced … Read more